Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.aafp.org › pubs › afpAtopic Dermatitis: Diagnosis and Treatment | AAFP

   www.aafp.org › pubs › afp

   • Αποθηκευμένο αντίγραφο

   15 Μαΐ 2020 · Ultraviolet phototherapy is a safe and effective treatment for moderate to severe atopic dermatitis when first-line treatments are not adequate. Antistaphylococcal antibiotics are effective...

2. www.aafp.org › pubs › afpAtopic Dermatitis: Updated Guidelines From the AAAAI/ACAAI Joint...

   www.aafp.org › pubs › afp

   • Αποθηκευμένο αντίγραφο

   • Treatment of atopic dermatitis with a midpotency topical corticosteroid once daily or a topical calcineurin inhibitor two to three times per week is safer and more effective for maintenance...

3. www.aafp.org › pubs › afpManagement of Atopic Dermatitis: Guideline from the American ......

   www.aafp.org › pubs › afp

   • Αποθηκευμένο αντίγραφο

   1 Δεκ 2014 · Topical corticosteroids are a mainstay of atopic dermatitis treatment. More than 100 randomized controlled trials have proven their effectiveness.

4. pmc.ncbi.nlm.nih.gov › articles › PMC6261117Treatment of Atopic Dermatitis with Biologic Drugs - PMC

   pmc.ncbi.nlm.nih.gov › articles › PMC6261117

   Atopic dermatitis (AD) is the most common inflammatory skin disease of childhood, affecting about 20% of children [1]. AD usually resolves before adolescence. However, it sometimes persists in adulthood (persistent AD), and in some cases the disease starts in adulthood (adult-onset AD) [2]. It is reported that the prevalence of childhood AD is ...

5. www.ncbi.nlm.nih.gov › pmc › articlesBiological therapies for atopic dermatitis: An update - PMC

   www.ncbi.nlm.nih.gov › pmc › articles

   19 Νοε 2018 · We reviewed the different biological treatments with a focus on novel targeted agents: Systemic immunotherapy (Omalizumab, Dupilumab, Lebrikizumab, Tralokinumab, Nemolizumab, Ustekinumab, Fezakinumab, Tezepelumab, Apremilast, allergen specific immunotherapy), and topical agents (Tofacitinib, Crisaborole).

6. www.jaad.org › article › S0190-9622(23)02878-5Guidelines of care for the management of atopic dermatitis in...

   www.jaad.org › article › S0190-9622(23)02878-5

   For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered. Multiple biologic therapies and Janus kinase (JAK)inhibitors have been approved since 2014 to treat AD.

7. onlinelibrary.wiley.com › doi › 10Treatment of atopic dermatitis: Recently approved drugs and...

   onlinelibrary.wiley.com › doi › 10

   8 Ιαν 2024 · The inhibition of the interleukin (IL)-31 receptor (IL-31R), the neurokinin-1-receptor (NK1R), and the histamine-H1-receptor (H1R) as well as the agonism at the kappa opioid receptor (KOR) are important targets in the treatment of atopic itch. Biologics are depicted in in green, JAKi in light blue.